ARTICLE | Company News
TeaRx Ltd., Roche deal
May 30, 2011 7:00 AM UTC
Roche granted newco TeaRx exclusive rights to develop and commercialize preclinical oral Factor Xa inhibitors in Russia and 11 other undisclosed countries. TeaRx will be responsible for conducting cl...